Therapeutic area

Psychiatric disorders – page 38

546 clinical trials
252 recruiting
147 conditions
26 countries

Clinical trials in Psychiatric disorders

546 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

546 clinical trials

Major depression

Not recruiting

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Aticaprant
Sponsor:Janssen Cilag International

Contact Research Centre

Rett syndrome

Not recruiting

Study on the Safety and Tolerability of Leriglitazone for Children with Rett Syndrome

Investigational

Study on the Safety and Tolerability of Leriglitazone for Children with Rett Syndrome

Investigational

Spain

Participants:0–17 years
Substances:Leriglitazone
Sponsor:Minoryx Therapeutics S.L.

Contact Research Centre

Insomnia

Not recruiting

Study to Determine Safe and Effective Dose of Daridorexant for Treating Insomnia in Children and Adolescents Aged 10 to 18 Years

Registered drug

Study to Determine Safe and Effective Dose of Daridorexant for Treating Insomnia in Children and Adolescents Aged 10 to 18 Years

Registered drug

Bulgaria

Participants:0–17 years
Substances:Daridorexant
Sponsor:Idorsia Pharmaceuticals Ltd.

Contact Research Centre

Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

Not recruiting

Registered drug

Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

Registered drug

Denmark

Participants:18–64 years
Substances:Semaglutide
Sponsor:Psykiatrisk Center Kobenhavn

Contact Research Centre

Drug use disorder

Not recruiting

Study of Intranasal Oxytocin Treatment for Patients with Benzodiazepine Withdrawal Symptoms: A Comparison with Placebo during Diazepam Dose Reduction

Registered drug

Study of Intranasal Oxytocin Treatment for Patients with Benzodiazepine Withdrawal Symptoms: A Comparison with Placebo during Diazepam Dose Reduction

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Oxytocin
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Bipolar disorder

Not recruiting

Study on Memantine Hydrochloride for Adolescents with Bipolar Disorder

Registered drug

Study on Memantine Hydrochloride for Adolescents with Bipolar Disorder

Registered drug

Italy

Participants:0–17 years
Substances:Memantine Hydrochloride
Sponsor:Ospedale Pediatrico Bambino Gesu

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

InvestigationalNo placebo

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Valiltramiprosate
Sponsor:Alzheon Inc.

Contact Research Centre

Fragile X syndrome

Not recruiting

Study on the Effects and Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Investigational

Study on the Effects and Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Investigational

Ireland

Participants:0–17 years · 18–64 years
Substances:Cannabidiol
Sponsor:Harmony Biosciences Management Inc.

Contact Research Centre

Depression

Not recruiting

Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

Registered drugNo placebo

Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nitrogen
Sponsor:Centre Hospitalier Regional Universitaire De Tours

Contact Research Centre

Circadian rhythm sleep disorder

Not recruiting

Study on the Effects of Tasimelteon for Patients with Delayed Sleep-Wake Phase Disorder

Registered drug

Study on the Effects of Tasimelteon for Patients with Delayed Sleep-Wake Phase Disorder

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Tasimelteon
Sponsor:Vanda Pharmaceuticals Inc.

Contact Research Centre

Alcohol use disorder

Not recruiting

Study of Single Dose Psilocybin Treatment for Adults with Alcohol Use Disorder

InvestigationalNo placebo

Study of Single Dose Psilocybin Treatment for Adults with Alcohol Use Disorder

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
Sponsor:Region Hovedstaden

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

A study of low-dose interleukin-2 (aldesleukin) treatment in patients with early Alzheimer's Disease

Registered drug

A study of low-dose interleukin-2 (aldesleukin) treatment in patients with early Alzheimer's Disease

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Aldesleukin
Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Contact Research Centre

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Sodium Chloride25 clinical trials Trospium Chloride17 clinical trials Xanomeline Tartrate16 clinical trials Cannabidiol15 clinical trials Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol14 clinical trials Florquinitau (18F)14 clinical trials Oxytocin13 clinical trials Aripiprazole12 clinical trials Florbetaben (18F)12 clinical trials

Psychiatric disorders – page 38

Conditions in this area

Clinical trials in Psychiatric disorders

546 clinical trials

Major depression

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

Rett syndrome

Study on the Safety and Tolerability of Leriglitazone for Children with Rett Syndrome

Insomnia

Study to Determine Safe and Effective Dose of Daridorexant for Treating Insomnia in Children and Adolescents Aged 10 to 18 Years

Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

Drug use disorder

Study of Intranasal Oxytocin Treatment for Patients with Benzodiazepine Withdrawal Symptoms: A Comparison with Placebo during Diazepam Dose Reduction

Bipolar disorder

Study on Memantine Hydrochloride for Adolescents with Bipolar Disorder

Dementia Alzheimer's type

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

Fragile X syndrome

Study on the Effects and Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Depression

Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

Circadian rhythm sleep disorder

Study on the Effects of Tasimelteon for Patients with Delayed Sleep-Wake Phase Disorder

Alcohol use disorder

Study of Single Dose Psilocybin Treatment for Adults with Alcohol Use Disorder

Dementia Alzheimer's type

A study of low-dose interleukin-2 (aldesleukin) treatment in patients with early Alzheimer's Disease

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.